← Back
Data updated: Jul 17, 2026
BLACKSMITH BRANDS
Pharma Pharmaceuticals
BLACKSMITH BRANDS is a pharmaceutical company with 1 FDA-approved products.
1997
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
BLACKSMITH BRANDS's Key Drugs
BLACKSMITH BRANDS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
BLACKSMITH BRANDS's Recent FDA Approvals
New NDA/BLA approvals for BLACKSMITH BRANDS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
BLACKSMITH BRANDS's Therapeutic Areas
Disease areas where BLACKSMITH BRANDS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
BLACKSMITH BRANDS Pipeline Snapshot
Active clinical trials for BLACKSMITH BRANDS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1997-01-03
- Latest
- 2004-07-15
- Applications
- 1